Literature DB >> 11997257

In vivo microdialysis for determination of nasal liquid ion composition.

Barbara R Grubb1, James L Chadburn, Richard C Boucher.   

Abstract

Airway surface liquid (ASL) contains substances important in mucociliary clearance and airway defense. Little is known about substance concentrations in ASL because of its small volume and sampling difficulties. We used in vivo microdialysis (IVMD) to sample liquid lining the nasal cavity without net volume removal and incorporated into IVMD a potential difference (PD) electrode to assess airway integrity. The cystic fibrosis (CF) mouse nasal epithelia exhibit ion transport defects identical to those in CF human airways and, thus, are a good model for CF disease. We determined that nasal liquid [Na+] (107 +/- 4 mM normal; 111 +/- 9 mM CF) and [Cl-] (120 +/- 6 mM normal; 122 +/- 4 mM CF) did not differ between genotypes. The nasal liquid [K+] (8.7 +/- 0.4 mM) was significantly less in normal than in CF mice (16.6 +/- 4 mM). IVMD accurately samples nasal liquid for ionic composition. The ionic composition of nasal liquid in the normal and CF mice is similar.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11997257     DOI: 10.1152/ajpcell.00612.2001

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  2 in total

1.  Brain microdialysis as a tool to explore the ionic profile of the brain extracellular space in neurocritical patients: a methodological approach and feasibility study.

Authors:  Tamara Martínez-Valverde; Marian Vidal-Jorge; Noelia Montoya; Angela Sánchez-Guerrero; Susana Manrique; Francisca Munar; Maria-Dolors Pellegri; Maria-Antonia Poca; Juan Sahuquillo
Journal:  J Neurotrauma       Date:  2015-01-01       Impact factor: 5.269

2.  In vivo determination of mouse olfactory mucus cation concentrations in normal and inflammatory states.

Authors:  Senthil Selvaraj; Kevin Liu; Alan M Robinson; Victoria A Epstein; David B Conley; Robert C Kern; Claus-Peter Richter
Journal:  PLoS One       Date:  2012-07-20       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.